Imiquimod, an immune response modifier, has been demonstrated to be safe and effective
in the treatment of external genital and perianal warts caused by human papillomavirus …

Background and Objective: Imiquimod (Aldara) is an immune response modifier used
primarily to treat anogenital warts. Imiquimod induces cytokines and enhances cell …

Imiquimod is a unique topical therapeutic agent useful in the treatment of external genital
and perianal warts (condyloma acuminata) in adults. The authors report a case of a 21-year …

Imiquimod, an imidazoquinoline amine, is an immune response modifier recently approved
for the topical treatment of external genital and perianal warts. Although the majority of …

Papillomavirus infections are very common and cause various benign and malignant
lesions, most notably condyloma acuminatum, anogenital cancer, laryngeal papilloma and …

Anogenital condyloma acuminatum (genital warts) is the most commonly diagnosed
sexually transmitted viral disease in the United States. At least 14 of the more than 60 types …

Genital human papillomavirus (HPV) is a common, usually transient, dermatologic infection
transmitted by genital contact that can cause a variety of anogenital diseases, including …

Human papillomavirus (HPV)-related diseases, including cancers, low-grade neoplasia,
genital warts, and recurrent respiratory papillomatosis, have a substantial impact on public …

A bstract Background: Human papillomaviruses (HPV) are common human pathogens and
are classified into more than 80 different types. These viruses produce benign warts in many …

Genital human papillomavirus (HPV) infection is very common, and often sub-clinical and
usually resolves without any treatment. Genital warts are caused by HPV 6/11 infection and …